Oriola Corp - Company Profile
Powered by 
All the sales intelligence you need on Oriola Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Oriola Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Oriola Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Oriola Corp (Oriola) specializes in the wholesale and distribution of pharmaceuticals and healthcare products. Its primary operations include pharmaceutical logistics, dose dispensing services, and the wholesale of traded goods, over-the-counter (OTC) products, parallel import, and special licensed medicines. Oriola's product range includes health and wellbeing products. It offers vitamins, food and food supplements, sports nutrients, wound care and beauty and makeup products. The company also offers a selection of products such as wound care, bandage and support accessories, and medicine dispensers. Oriola's products are available through pharmacies, online pharmacy stores, and grocery stores. The company primarily operates in the Finnish and Swedish markets. Oriola is headquartered in Espoo, Finland.
Headquarters
Finland
Address
Orionintie 5, Espoo, 02200
Website
www.oriola.com
Telephone
358 10 42999
No of Employees
934
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ORIOLA (HEL)
Revenue (2024)
$1.8B
12.4%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
2.9%
(2024 vs 2023)
Market Cap*
$194.0M
Net Profit Margin (2024)
XYZ
13.7%
(2024 vs 2023)
* As of and is in US$
Oriola Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Vitamins | Logistics | Gefilus |
| Food Supplements | Special License Preparations | Lysi |
| Sports Nutrients | Dose Distribution | Pansuola |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In January, the company entered into a partnership with GSK to ensure reliable, temperature-controlled distribution of flu vaccines during Sweden’s flu season. |
| 2025 | Contracts/Agreements | In August, the company entered into a partnership with Molnlycke Health Care to be their exclusive distributor for pharmacy wound care products in Finland. |
| 2025 | Divestiture | In April, the company sold Svensk dos AB to Apotekstjanst Sverige AB. |
Competitor Comparison
| Key Parameters | Oriola Corp | Cencora Inc | Raisio plc | Chiesi Pharmaceuticals GmbH | Oral Hammaslaakarit Oyj |
|---|---|---|---|---|---|
| Headquarters | Finland | United States of America | Finland | Austria | Finland |
| City | Espoo | Conshohocken | Raisio | Vienna | Espoo |
| State/Province | - | Pennsylvania | - | Wien | - |
| No. of Employees | 934 | 51,000 | 362 | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Heikki Westerlund | Chairman | Executive Board | 2023 | 60 |
| Katarina Gabrielson | Chief Executive Officer | Senior Management | 2022 | 57 |
| Mats Danielsson | Chief Financial Officer | Senior Management | 2024 | 57 |
| Maria Lundell | Chief People Officer | Senior Management | 2025 | 55 |
| Mikael Nurmi | Chief Digital Officer | Senior Management | 2023 | 59 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer